Lawsuit Overview
An investor in shares of Teva Pharmaceutical Industries Limited (NYSE: TEVA) filed a lawsuit in the U.S. District Court for the Eastern District of Pennsylvania over alleged violations of Federal Securities Laws by Teva Pharmaceutical Industries Limited in connection with certain allegedly false and misleading statements made between August 4, 2017 and May 10, 2019. Israel based Teva...
You must register (for free) or login to view the entire case.